NCT00064532

Completed

Serum Sex Hormone Levels and Subclinical Atherosclerosis - A...

Northwestern University Source

Other study identifiers

Sponsor study identifier

1226

Secondary identifiers

R01HL074338

NIH

Study Type

observational

Actual enrollment (reported)

6,173

Locations

0 countries

Sites

N/A

Timeline

Study Start

July 2003

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2008

Actual (reported)

Study Completion

June 2008

Actual (reported)

Brief Summary

To assess the associations of serum sex hormones with the presence and progression of subclinical atherosclerosis.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 6,173 participants
Study completion date: June 2008
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
July 2003
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
July 8, 2003
Actual (reported)
First Posted
July 10, 2003
Actual (reported)
Primary Completion
June 2008
Actual (reported)
Study Completion
June 2008
Actual (reported)

Last Updated: December 3, 2014
Status Verified: November 2013
Last Update Submitted: December 2, 2014

Conditions

Atherosclerosis Cardiovascular Diseases Coronary Arteriosclerosis Coronary Disease Heart Diseases

Outcome Measures

Primary Outcomes (1)

Coronary artery calcium
Baseline

Eligibility Criteria

Age45 Years - 84 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

Community sample of African-American, Chinese-American, Caucasian, and Hispanic residents drawn from six regions in the United States: Baltimore City and Baltimore County, Maryland; Chicago, Illinois; Forsyth County, North Carolina; Los Angeles County, California; New York, New York; and St. Paul, Minnesota.

You may not qualify if:

Age younger than 45 or older than 84 years

Sponsors & Collaborators

National Heart, Lung, and Blood Institute (NHLBI)
NIHcollaborator
Northwestern University
Otherlead

MeSH Terms

Conditions

Cardiovascular DiseasesAtherosclerosisCoronary Artery DiseaseCoronary DiseaseHeart Diseases

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesMyocardial Ischemia

Study Officials

Susan Gapstur
Northwestern University
PRINCIPAL INVESTIGATOR

Enrollment

6,173 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: CROSS SECTIONAL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Professor in Preventive Medicine and Geriatrics and Internal Medicine

Study Record Dates

First Submitted

July 8, 2003

First Posted

July 10, 2003

Study Start

July 2003

Date type not reported

This date has not been verified as actual or estimated.

Neighborhoods and CVD Risk in a Multiethnic Cohort - Ancillary to MESA

Completed

NCT00024596

Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)

Completed

NCT00005679

Pathobiological Determinants of Atherosclerosis in Youth (PDAY)

Completed

NCT00081705

Estrogen Receptor Variants, HDL, and Atherosclerosis

Completed

NCT00005349

Epidemiology of Coronary Artery Calcification

Completed

NCT00091754

Atherosclerosis, Plaque and CVD in Communities

Completed

Physician-diagnosed heart attack

Physician-diagnosed angina or taking nitroglycerin

Physician-diagnosed stroke or TIA

Physician-diagnosed heart failure

Current atrial fibrillation

Having undergone procedures related to cardiovascular disease (CABG, angioplasty, valve replacement, pacemaker or defibrillator implantation, any surgery on the heart or arteries)

Active treatment for cancer

Pregnancy

Any serious medical condition which would prevent long-term participation

Weight \>300 pounds

Cognitive inability as judged by the interviewer

Living in a nursing home or on the waiting list for a nursing home

Plans to leave the community within five years

Language barrier (speaks other than English, Spanish, Cantonese or Mandarin)

+1 more criteria

Contact the study team to confirm eligibility.

Primary Completion

June 2008

Actual (reported)

Study Completion

June 2008

Actual (reported)

Last Updated

December 3, 2014

Record last verified: 2013-11

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00064532
Data provider: ClinicalTrials.gov
Source updated: 2014-12-03
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:34:28 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may not qualify if:

Sponsors & Collaborators

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record